MMP9 and cancer: All derivatives were initially screened using the MTT assay to evaluate cytotoxic effects on normal colonocytes for safety assessment, followed by evaluation of their anti-cancer potential on HCT 116 cells overexpressing MMP-9 and MAO-A.